Check the

RAYTEK SCIENTIFIC LIMITED

Company
RAYTEK SCIENTIFIC LIMITED (02407019)

RAYTEK SCIENTIFIC

Phone: 01142 749 575
A⁺ rating

KEY FINANCES

Year
2016
Assets
£289.95k ▼ £-43.23k (-12.98 %)
Cash
£0k ▼ £-0.01k (-61.54 %)
Liabilities
£43.37k ▼ £-82.36k (-65.50 %)
Net Worth
£246.58k ▲ £39.13k (18.86 %)

REGISTRATION INFO

Company name
RAYTEK SCIENTIFIC LIMITED
Company number
02407019
Status
Active
Categroy
Private Limited Company
Date of Incorporation
21 Jul 1989
Age - 35 years
Home Country
United Kingdom

CONTACTS

Website
raytek.co.uk
Phones
01142 749 575
01142 749 919
Registered Address
13-17 PARADISE SQUARE,
SHEFFIELD,
SOUTH YORKSHIRE,
S1 2DE

ECONOMIC ACTIVITIES

62090
Other information technology service activities

LAST EVENTS

02 Aug 2016
Confirmation statement made on 21 July 2016 with updates
27 May 2016
Total exemption small company accounts made up to 31 August 2015
18 Aug 2015
Annual return made up to 21 July 2015 with full list of shareholders Statement of capital on 2015-08-18 GBP 51

See Also


Last update 2018

RAYTEK SCIENTIFIC LIMITED DIRECTORS

Antony Charles Dewar

  Acting
Role
Secretary
Nationality
British
Address
26 Norton Park View, Sheffield, South Yorkshire, S8 8GS
Name
DEWAR, Antony Charles

Antony Charles Dewar

  Acting PSC
Occupation
Company Director
Role
Director
Age
63
Nationality
British
Address
26 Norton Park View, Sheffield, South Yorkshire, S8 8GS
Country Of Residence
United Kingdom
Name
DEWAR, Antony Charles
Notified On
6 April 2016
Nature Of Control
Ownership of shares – 75% or more

Michael Peter Dewar

  Resigned
Resigned
17 July 2014
Occupation
Dentist
Role
Director
Age
69
Nationality
British
Address
20 Tylney Road, Chesterfield, Derbyshire, S40 3NZ
Name
DEWAR, Michael Peter

Gunter Dietzel

  Resigned
Appointed
01 December 1991
Resigned
31 May 2014
Occupation
Director
Role
Director
Age
83
Nationality
German
Address
Schonblick Strabe 33, 7541 Straubenhardt-Schwann, Germany
Country Of Residence
Germany
Name
DIETZEL, Gunter

REVIEWS


Check The Company
Excellent according to the company’s financial health.